{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:57:06Z","timestamp":1774497426305,"version":"3.50.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.hlc.2024.12.007","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T21:31:14Z","timestamp":1738877474000},"page":"225-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unmet Needs and Opportunities for Australian Innovation and Clinical Research to Improve Quality of Life and Outcomes in Patients With Peripheral Artery Disease"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8013-5658","authenticated-orcid":false,"given":"Belinda J.","family":"Parmenter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7353-0932","authenticated-orcid":false,"given":"Mary M.","family":"Kavurma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Arnott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-6213","authenticated-orcid":false,"given":"Sarah J.","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7964-819X","authenticated-orcid":false,"given":"Steven G.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1154-3011","authenticated-orcid":false,"given":"Michael P.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Golledge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8076-8789","authenticated-orcid":false,"given":"Christopher D.","family":"Askew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreeya","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Hure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma A.","family":"Figtree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2024.12.007_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2024.12.007_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.amepre.2006.12.010","article-title":"Ethnic-specific prevalence of peripheral arterial disease in the United States","volume":"32","author":"Allison","year":"2007","journal-title":"Am J Prev Med"},{"issue":"Suppl S","key":"10.1016\/j.hlc.2024.12.007_bib3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.hlc.2024.12.007_bib4","article-title":"Cohort study examining the association between blood pressure and cardiovascular events in patients with peripheral artery disease","volume":"8","author":"Thomas Manapurathe","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hlc.2024.12.007_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1474515116687222","article-title":"Depression in patients with peripheral arterial disease: a systematic review","volume":"16","author":"Brostow","year":"2017","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.hlc.2024.12.007_bib6","series-title":"AIHW Cardiovascular Disease Data Tables. Cardiovascular Disease Data Tables","year":"2020"},{"key":"10.1016\/j.hlc.2024.12.007_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170705","article-title":"Geographic variation of the incidence rate of lower limb amputation in Australia from 2007\u201312","volume":"12","author":"Dillon","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.hlc.2024.12.007_bib8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ejvs.2020.05.037","article-title":"Editor's choice - trends in lower extremity amputation incidence in European Union 15+ countries 1990\u20132017","volume":"60","author":"Hughes","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.hlc.2024.12.007_bib9","series-title":"Facts and Figures","year":"2024"},{"key":"10.1016\/j.hlc.2024.12.007_bib10","series-title":"Australian Atlas of Healthcare Variation","year":"2016"},{"key":"10.1016\/j.hlc.2024.12.007_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12872-018-0835-z","article-title":"Presentation and outcomes of Indigenous Australians with peripheral artery disease","volume":"18","author":"Singh","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hlc.2024.12.007_bib12","series-title":"Disease Expenditure in Australia","year":"2019"},{"key":"10.1016\/j.hlc.2024.12.007_bib13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2024.12.007_bib14","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.hlc.2024.12.007_bib15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5694\/mja2.52482","article-title":"The National Cardiovascular Health Leaders\u2019 Research Forum- a new data-driven model placing research at the centre of improving patient outcomes","volume":"221","author":"Figtree","year":"2024","journal-title":"Med J Aust"},{"key":"10.1016\/j.hlc.2024.12.007_bib16","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.hlc.2021.04.016","article-title":"Outcomes and costs of open and endovascular revascularisation for chronic limb ischaemia in an Australian cohort","volume":"30","author":"Smith","year":"2021","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2024.12.007_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.10765","article-title":"Risk of major amputation in patients with intermittent claudication undergoing early revascularization","volume":"105","author":"Golledge","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.hlc.2024.12.007_bib18","first-page":"CD010512","article-title":"Endovascular revascularisation versus conservative management for intermittent claudication","volume":"3","author":"Fakhry","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hlc.2024.12.007_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/eurheartj\/ehab116","article-title":"Long-term outcomes following endovascular and surgical revascularization for peripheral artery disease: a propensity score-matched analysis","volume":"43","author":"Parvar","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2024.12.007_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/ans.16469","article-title":"The prescription of best medical therapy following infrainguinal bypass grafting in Australia and New Zealand: a multicentre Australasian audit","volume":"91","author":"Farah","year":"2021","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.hlc.2024.12.007_bib21","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jvs.2020.08.129","article-title":"The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery disease","volume":"73","author":"Nastasi","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.hlc.2024.12.007_bib22","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/ans.16886","article-title":"Variation in treatment and outcomes for patients with chronic limb-threatening ischaemia in New South Wales, Australia","volume":"91","author":"Choy","year":"2021","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.hlc.2024.12.007_bib23","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2024.12.007_bib24","series-title":"Peripheral Arterial Disease: Diagnosis and Management","article-title":"Guidance and guidelines","year":"2014"},{"key":"10.1016\/j.hlc.2024.12.007_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.666334","article-title":"\u03b23 adrenergic receptor stimulation promotes reperfusion in ischemic limbs in a murine diabetic model","volume":"12","author":"Bubb","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hlc.2024.12.007_bib26","first-page":"342","article-title":"A hidden problem: peripheral artery disease in women","volume":"9","author":"Kavurma","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.hlc.2024.12.007_bib27","doi-asserted-by":"crossref","DOI":"10.15420\/usc.2022.28","article-title":"The pink tax: sex and gender disparities in peripheral artery disease","volume":"18","author":"Martinez","year":"2024","journal-title":"US Cardiol"},{"key":"10.1016\/j.hlc.2024.12.007_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCRESAHA.121.320702","article-title":"Sex differences in peripheral artery disease","volume":"130","author":"Pabon","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2024.12.007_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCULATIONAHA.116.026668","article-title":"Sex bias is increasingly prevalent in preclinical cardiovascular research: implications for translational medicine and health equity for women: a systematic assessment of leading cardiovascular journals over a 10-year period","volume":"135","author":"Ramirez","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2024.12.007_bib30","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC Guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2024.12.007_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/2050312113516110","article-title":"One of the most urgent vascular circumstances: acute limb ischemia","volume":"1","author":"Acar","year":"2013","journal-title":"Sage Open Med"},{"key":"10.1016\/j.hlc.2024.12.007_bib32","series-title":"Vascular Surgery","first-page":"959","article-title":"Acute Limb Ischemia","author":"Ourel","year":"2005"},{"key":"10.1016\/j.hlc.2024.12.007_bib33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jvs.2005.01.037","article-title":"Skeletal muscle phenotype is associated with exercise tolerance in patients with peripheral arterial disease","volume":"41","author":"Askew","year":"2005","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.hlc.2024.12.007_bib34","doi-asserted-by":"crossref","first-page":"R943","DOI":"10.1152\/ajpregu.00480.2015","article-title":"Capillary ultrastructure and mitochondrial volume density in skeletal muscle in relation to reduced exercise capacity of patients with intermittent claudication","volume":"310","author":"Baum","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.hlc.2024.12.007_bib35","doi-asserted-by":"crossref","first-page":"H1425","DOI":"10.1152\/ajpheart.00232.2018","article-title":"Leg blood flow and skeletal muscle microvascular perfusion responses to submaximal exercise in peripheral arterial disease","volume":"315","author":"Meneses","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hlc.2024.12.007_bib36","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/ATVBAHA.119.312859","article-title":"Microvascular disease increases amputation in patients with peripheral artery disease","volume":"40","author":"Behroozian","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.hlc.2024.12.007_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028649","article-title":"Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study","volume":"9","author":"Kott","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.hlc.2024.12.007_bib38","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2024.12.007_bib39","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2024.12.007_bib40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the\u00a0FOURIER trial (further cardiovascular outcomes research with PCSK9\u00a0inhibition in subjects with elevated risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2024.12.007_bib41","series-title":"Cilostazol, Naftidrofuryl Oxalate, Pentoxifylline and Inositol Nicotinate for the Treatment of Intermittent Claudication in People with Peripheral Arterial Disease. Guidance and Guidelines","year":"2011"},{"key":"10.1016\/j.hlc.2024.12.007_bib42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/pds.4167","article-title":"Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany","volume":"26","author":"Castellsague","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.hlc.2024.12.007_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12872-018-0822-4","article-title":"Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database","volume":"18","author":"Real","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hlc.2024.12.007_bib44","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/CIRCRESAHA.121.318266","article-title":"New directions in therapeutic angiogenesis and\u00a0arteriogenesis in peripheral arterial disease","volume":"128","author":"Annex","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2024.12.007_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049858","volume":"11","author":"Bubb","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.hlc.2024.12.007_bib46","article-title":"Tumor necrosis factor\u2013related apoptosis-inducing ligand (TRAIL) promotes angiogenesis and ischemia-induced neovascularization via NADPH oxidase 4 (NOX4) and nitric oxide\u2013dependent mechanisms","volume":"4","author":"Di Bartolo","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hlc.2024.12.007_bib47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.freeradbiomed.2018.08.031","article-title":"TRAIL protects against endothelial dysfunction in\u00a0vivo and inhibits angiotensin-II-induced oxidative stress in vascular endothelial cells in\u00a0vitro","volume":"126","author":"Manuneedhi Cholan","year":"2018","journal-title":"Free Radic Biol"},{"key":"10.1016\/j.hlc.2024.12.007_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.isci.2018.12.037","article-title":"TRAIL-expressing monocyte\/macrophages are critical for reducing inflammation and atherosclerosis","volume":"12","author":"Cartland","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.hlc.2024.12.007_bib49","doi-asserted-by":"crossref","first-page":"712","DOI":"10.12659\/MSM.889514","article-title":"Association of circulating sTRAIL and high-sensitivity CRP with type 2 diabetic nephropathy and foot ulcers","volume":"19","author":"Ar\u0131k","year":"2013","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.hlc.2024.12.007_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn8760","article-title":"The generation of stable microvessels in ischemia is mediated by endothelial cell derived TRAIL","volume":"10","author":"Cartland","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.hlc.2024.12.007_bib51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1043-6618(05)80065-9","article-title":"Treatment with low dose metformin in patients with peripheral vascular disease","volume":"25","author":"Montanari","year":"1992","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.hlc.2024.12.007_bib52","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/00005344-198409000-00027","article-title":"Metformin improves peripheral vascular flow in nonhyperlipidemic patients with arterial disease","volume":"6","author":"Sirtori","year":"1984","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.hlc.2024.12.007_bib53","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jvs.2013.09.061","article-title":"Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model","volume":"61","author":"Takahashi","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.hlc.2024.12.007_bib54","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10735-018-9801-4","article-title":"Favorable outcomes of metformin on coronary microvasculature in experimental diabetic cardiomyopathy","volume":"49","author":"Abdel-Hamid","year":"2018","journal-title":"J\u00a0Mol Histol"},{"key":"10.1016\/j.hlc.2024.12.007_bib55","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.mayocp.2019.06.015","article-title":"Effect of metformin on microvascular endothelial function in polycystic ovary syndrome","volume":"94","author":"Heidari","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hlc.2024.12.007_bib56","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.3390\/jcm9103228","article-title":"Acute effects of metformin and vildagliptin after a lipid-rich meal on postprandial microvascular reactivity in patients with type 2 diabetes and obesity: a randomized trial","volume":"9","author":"Schiappacassa","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.hlc.2024.12.007_bib57","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1093\/brain\/awy231","article-title":"Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial","volume":"141","author":"Bassez","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.hlc.2024.12.007_bib58","article-title":"Risk factors for sarcopenia in the elderly with type 2 diabetes mellitus and the effect of metformin","volume":"2020","author":"Chen","year":"2020","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.hlc.2024.12.007_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13936","article-title":"Disuse-induced muscle fibrosis, cellular senescence, and senescence-associated secretory phenotype in older adults are alleviated during re-ambulation with metformin pre-treatment","volume":"22","author":"Petrocelli","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.hlc.2024.12.007_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biomaterials.2017.09.034","article-title":"Biofabricating atherosclerotic plaques: in\u00a0vitro engineering of a three-dimensional human fibroatheroma model","volume":"150","author":"Mallone","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.hlc.2024.12.007_bib61","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.mric.2022.04.008","article-title":"Emergent magnetic resonance angiography for evaluation of the thoracoabdominal and peripheral vasculature","volume":"30","author":"Ludwig","year":"2022","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"10.1016\/j.hlc.2024.12.007_bib62","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ejvs.2021.08.017","article-title":"A\u00a0systematic review and critical appraisal of peri-procedural tissue perfusion techniques and their clinical value in patients with peripheral arterial disease","volume":"62","author":"Wermelink","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.hlc.2024.12.007_bib63","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jvs.2014.01.041","article-title":"Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery","volume":"59","author":"Katsanos","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.hlc.2024.12.007_bib64","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard Balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2024.12.007_bib65","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jcin.2019.10.059","article-title":"The IN.PACT DEEP clinical drug-coated balloon trial: 5-year outcomes","volume":"13","author":"Zeller","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hlc.2024.12.007_bib66","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2024.12.007_bib67","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jvir.2023.12.574","article-title":"Mortality, safety, and effectiveness of paclitaxel-containing balloons and stents in the femoropopliteal artery: systematic review and meta-analysis of randomized controlled trials since 2018","volume":"35","author":"Briody","year":"2024","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.hlc.2024.12.007_bib68","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa2005206","article-title":"Mortality with paclitaxel-coated devices in peripheral artery disease","volume":"383","author":"Nordanstig","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2024.12.007_bib69","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jacbts.2021.04.008","article-title":"Macrophage polarization as a novel therapeutic target for endovascular intervention in peripheral artery disease","volume":"6","author":"Tan","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.hlc.2024.12.007_bib70","first-page":"135","article-title":"Atherectomy in peripheral artery disease: a review","volume":"29","author":"Bhat","year":"2017","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.hlc.2024.12.007_bib71","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jcin.2021.03.036","article-title":"Principles of intravascular lithotripsy for calcific plaque modification","volume":"14","author":"Kereiakes","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hlc.2024.12.007_bib72","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/CIR.0b013e31824c39ba","article-title":"A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association","volume":"125","author":"Hirsch","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2024.12.007_bib73","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1358863X14559092","article-title":"Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis","volume":"20","author":"Parmenter","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.hlc.2024.12.007_bib74","first-page":"452","article-title":"Resistance training as a treatment for older persons with peripheral artery disease: a systematic review and meta-analysis","volume":"54","author":"Parmenter","year":"2020","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.hlc.2024.12.007_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2011.04.024","article-title":"A systematic review of randomized controlled trials: walking vs alternative exercise prescription as treatment for intermittent claudication","volume":"218","author":"Parmenter","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hlc.2024.12.007_bib76","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40279-014-0261-z","article-title":"Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis","volume":"45","author":"Parmenter","year":"2015","journal-title":"Sports Med"},{"key":"10.1016\/j.hlc.2024.12.007_bib77","first-page":"CD005262","article-title":"Pentoxifylline for intermittent claudication","volume":"9","author":"Salhiyyah","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hlc.2024.12.007_bib78","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jsams.2013.10.251","article-title":"Exercise & Sports Science Australia (ESSA) position statement on exercise prescription for patients with peripheral arterial disease and intermittent claudication","volume":"17","author":"Askew","year":"2014","journal-title":"J\u00a0Sci Med Sport"},{"key":"10.1016\/j.hlc.2024.12.007_bib79","article-title":"Exercise training for intermittent claudication: an evidence-based guideline for practitioners","volume":"6","author":"Harwood","year":"2020","journal-title":"BMJ Open Sp Ex Med"},{"key":"10.1016\/j.hlc.2024.12.007_bib81","first-page":"CD000990","article-title":"Exercise for intermittent claudication","volume":"12","author":"Lane","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hlc.2024.12.007_bib82","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fcvm.2018.00173","article-title":"Are there limitations to exercise benefits in peripheral arterial disease?","volume":"5","author":"Zakari","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hlc.2024.12.007_bib83","article-title":"Network meta-analysis comparing the outcomes of treatments for intermittent claudication tested in randomized controlled trials","volume":"10","author":"Thanigaimani","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hlc.2024.12.007_bib84","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s40279-016-0635-5","article-title":"Combined lower limb revascularisation and supervised exercise training for patients with peripheral arterial disease: a systematic review of randomised controlled trials","volume":"47","author":"Men\u00eases","year":"2017","journal-title":"Sports Med"},{"key":"10.1016\/j.hlc.2024.12.007_bib85","series-title":"National Government Information Sharing Strategy: Unlocking Government Information Assets to Benefit the Broader Community","year":"2009"},{"key":"10.1016\/j.hlc.2024.12.007_bib86","series-title":"High-Level Principles for Data Integration Involving Commonwealth Data for Statistical and Research Purposes","year":"2010"},{"key":"10.1016\/j.hlc.2024.12.007_bib87","series-title":"Measuring and Valuing Health Benefits for Economic Evaluation","first-page":"1","author":"Brazier","year":"2016"},{"key":"10.1016\/j.hlc.2024.12.007_bib88","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.0326","article-title":"Selecting and implementing patient-reported outcome and experience measures to assess health system performance","volume":"3","author":"Bull","year":"2022","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.hlc.2024.12.007_bib89","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1479-5868-8-99","article-title":"The economic benefits of reducing physical inactivity: an Australian example","volume":"8","author":"Cadilhac","year":"2011","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/j.hlc.2024.12.007_bib90","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ehjqcco\/qcac054","article-title":"The cost-effectiveness of Rivaroxaban with or without aspirin in the COMPASS trial","volume":"9","author":"Lamy","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144395062401967X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144395062401967X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:50:52Z","timestamp":1741189852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S144395062401967X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S144395062401967X"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2024.12.007","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmet Needs and Opportunities for Australian Innovation and Clinical Research to Improve Quality of Life and Outcomes in Patients With Peripheral Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2024.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}